Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 16.91%1.8B | 14.91%6.67B | 13.18%4.63B | 20.08%3.19B | 13.03%1.54B | -25.40%5.8B | -35.52%4.09B | -42.23%2.66B | -39.29%1.36B | -23.94%7.78B |
| Operating income | 16.91%1.8B | 14.91%6.67B | 13.18%4.63B | 20.08%3.19B | 13.03%1.54B | -25.40%5.8B | -35.52%4.09B | -42.23%2.66B | -39.29%1.36B | -23.94%7.78B |
| Cost of sales | -16.00%-1.03B | -13.83%-3.9B | -14.54%-2.67B | -15.95%-1.81B | -12.65%-890.59M | 10.44%-3.42B | 20.26%-2.33B | 28.06%-1.56B | 31.87%-790.6M | 29.19%-3.82B |
| Operating expenses | -16.00%-1.03B | -13.83%-3.9B | -14.54%-2.67B | -15.95%-1.81B | -12.65%-890.59M | 10.44%-3.42B | 20.26%-2.33B | 28.06%-1.56B | 31.87%-790.6M | 29.19%-3.82B |
| Gross profit | 18.16%768.77M | 16.46%2.77B | 11.36%1.96B | 25.98%1.38B | 13.56%650.63M | -39.85%2.38B | -48.61%1.76B | -54.89%1.09B | -47.22%572.95M | -18.06%3.96B |
| Selling expenses | -15.44%-50.97M | 13.54%-210.44M | 10.17%-150.22M | 11.20%-90.95M | 1.05%-44.15M | -23.91%-243.39M | -20.31%-167.22M | -24.86%-102.42M | -31.96%-44.62M | -30.78%-196.42M |
| Administrative expenses | -12.76%-215.52M | 6.91%-801.88M | -9.07%-608.88M | -5.42%-397.05M | -7.70%-191.12M | -5.11%-861.42M | 4.32%-558.27M | -7.35%-376.64M | -3.60%-177.45M | 2.16%-819.58M |
| Research and development expenses | 7.90%-126.99M | 3.45%-593.26M | 10.55%-433.07M | 13.06%-285.75M | 18.63%-137.88M | 13.19%-614.49M | 5.65%-484.14M | -1.61%-328.69M | -4.53%-169.44M | 0.15%-707.86M |
| Impairment and provision | -415.95%-6.5M | -522.33%-72.61M | -260.87%-35.82M | -508.97%-29.83M | 34.62%2.06M | -17.81%-11.67M | 37.74%-9.93M | 145.30%7.3M | -86.98%1.53M | 61.60%-9.9M |
| -Other impairment is provision | -415.95%-6.5M | -522.33%-72.61M | -260.87%-35.82M | -508.97%-29.83M | 34.62%2.06M | -17.81%-11.67M | 37.74%-9.93M | 145.30%7.3M | -86.98%1.53M | 61.60%-9.9M |
| Special items of operating profit | -142.74%-34.43M | -58.98%166.65M | -19.82%188.85M | -45.83%133.47M | -28.45%80.56M | 19.73%406.29M | -21.67%235.55M | -12.02%246.4M | 649.72%112.59M | -42.72%339.35M |
| Operating profit | -7.14%334.37M | 19.42%1.26B | 18.71%916.2M | 31.15%709.05M | 21.83%360.08M | -58.79%1.06B | -68.70%771.83M | -72.05%540.64M | -58.35%295.55M | -30.72%2.57B |
| Financing cost | -3.31%-2.97M | -34.15%-12.75M | -154.35%-9.39M | -147.67%-6.26M | -401.40%-2.87M | -60.77%-9.51M | -197.66%-3.69M | 9.00%-2.53M | 46.75%-573K | 43.85%-5.91M |
| Share of profits of associates | 4,597.62%1.97M | 48.36%36.88M | 134.91%3.14M | 50.63%-2.69M | 113.33%42K | 1,246.15%24.86M | -137.91%-8.98M | -80.10%-5.46M | -125.93%-315K | -106.56%-2.17M |
| Earning before tax | -6.68%333.37M | 19.96%1.29B | 19.86%909.95M | 31.44%700.1M | 21.24%357.25M | -58.06%1.07B | -69.49%759.16M | -72.38%532.65M | -58.48%294.66M | -31.35%2.56B |
| Tax | 1.42%-32.22M | -16.92%-159.74M | -99.19%-117.47M | -116.10%-86.95M | -115.94%-32.68M | 55.40%-136.63M | 79.47%-58.98M | 83.68%-40.24M | 81.50%-15.13M | 28.82%-306.31M |
| After-tax profit from continuing operations | -7.21%301.16M | 20.40%1.13B | 13.18%792.48M | 24.52%613.15M | 16.11%324.57M | -58.43%935.76M | -68.19%700.18M | -70.72%492.42M | -55.48%279.53M | -31.68%2.25B |
| Earning after tax | -7.21%301.16M | 20.40%1.13B | 13.18%792.48M | 24.52%613.15M | 16.11%324.57M | -58.43%935.76M | -68.19%700.18M | -70.72%492.42M | -55.48%279.53M | -31.68%2.25B |
| Minority profit | -55.42%-3.17M | 55.07%-5.93M | 23.45%-7.77M | 35.69%-4.32M | 16.55%-2.04M | 26.66%-13.19M | -9.13%-10.15M | -53.44%-6.72M | 0.61%-2.44M | -156.87%-17.99M |
| Profit attributable to shareholders | -6.82%304.32M | 19.35%1.13B | 12.66%800.25M | 23.71%617.47M | 15.83%326.61M | -58.17%948.95M | -67.86%710.33M | -70.40%499.13M | -55.27%281.97M | -31.28%2.27B |
| Basic earnings per share | -5.62%0.84 | 17.47%3.16 | 8.46%2.18 | 20.00%1.68 | 17.11%0.89 | -57.03%2.69 | -67.05%2.01 | -69.89%1.4 | -55.81%0.76 | -30.60%6.26 |
| Diluted earnings per share | -5.62%0.84 | 17.47%3.16 | 8.46%2.18 | 20.00%1.68 | 17.11%0.89 | -57.03%2.69 | -67.05%2.01 | -69.89%1.4 | -55.81%0.76 | -30.44%6.26 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.